SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000254
Filing Date
2021-07-06
Accepted
2021-07-06 13:18:52
Documents
14
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. avricore6kmarch2021.htm 6-K 11324
2 EXHIBIT 99.1 nr_ex99z1.htm EX-99.1 13823
3 EXHIBIT 99.2 notice_ex99z2.htm EX-99.2 8806
4 EXHIBIT 99.3 infocirc_ex99z3.htm EX-99.3 248848
5 EXHIBIT 99.4 fop_ex99z4.htm EX-99.4 849
6 EXHIBIT 99.5 fsreq_ex99z5.htm EX-99.5 642
7 EXHIBIT 99.6 nr_ex99z6.htm EX-99.6 11936
8 IMAGE nrex99z1_1.jpg GRAPHIC 5102
9 IMAGE noticeex99z2_1.jpg GRAPHIC 5250
10 IMAGE infocircex99z3_1.jpg GRAPHIC 5250
11 IMAGE fopex99z4_1.jpg GRAPHIC 359696
12 IMAGE fopex99z4_2.jpg GRAPHIC 319341
13 IMAGE fsreqex99z5_1.jpg GRAPHIC 182200
14 IMAGE nrex99z6_1.jpg GRAPHIC 5250
  Complete submission text file 0001052918-21-000254.txt   1513063
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211073421
SIC: 2834 Pharmaceutical Preparations